Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: Apr 21, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
April 19, 2005)
Last Price
(
April 12, 2005)
% Change
Agilent
A
20.77
21.36
-2.76
Applied Biosystems
ABI
20.28
20.69
-1.98
BD
BDX
56.71
58.51
-3.08
Beckman
BEC
66.29
67.33
-1.54
Bio-Rad
BIO
50.06
50.05
0.02
Bruker
BRKR
3.4
3.6
-5.56
GE
GE
36.0
36.09
-0.25
Harvard Bio
HBIO
3.65
3.81
-4.20
Invitrogen
IVGN
70.93
72.33
-1.94
Molecular Devices
MDCC
19.54
19.88
-1.71
PerkinElmer
PKI
19.6
20.4
-3.92
Sigma
SIAL
58.49
60.55
-3.40
Stratagene
STGN
8.01
8.65
-7.40
Thermo
TMO
24.77
24.85
-0.32
Waters
WAT
34.87
36.16
-3.57
Index Average 
32.89
33.62
-2.16

Bio-Rad Takes Small Gain as Index Falls

Shares in Bio-Rad Laboratories improved a fraction of a percent for the five-day period ended Tuesday, and the company, which is making an unsolicited bid for reagents player BioSource, was the only gainer among the 15 companies whose shares are tracked in the BioCommerce Week Index.

Stratagene led losers for the week with its shares falling 7 percent after announcing last week that it had exclusively licensed intellectual property held by the Sidney Kimmel Cancer Center of San Diego.

Bruker was down 5 percent for the week after launching its ClinProt Micro solution for clinical proteomics and peptide/protein biomarkers at the American Association for Cancer Research conference in Anaheim, Calif., this week.

Overall, the index dropped 2 percent for the week, closing at $32.89, its lowest point since Nov. 2 and its fifth losing period in the last six weeks. Still, the index outperformed the Dow and the S&P 500, which finished the five-day period down approximately 3.5 percent, and the Nasdaq, which was down 2.7 percent. The Amex pharma index was up 2.5 percent for the period, while the Amex biotech index closed up a fraction of a percent.

File Attachments